NEO hitting MINOLA on stockfetcher

NEO. NeoGenomics, Inc., together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories in the United States. It operates through Clinical Services and Pharma Services segments. The company laboratories provide genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, pharmaceutical firms, and other clinical laboratories. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients' oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. The company has a strategic alliance with Pharmaceutical Product Development Inc. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

NOTE: NEO like LXFR and NTWK came out of the MINOLA filter I have in stockfetcher.

TECHNICAL:
4 Days Breakout on previous high of $15.50 reaching a high of $19.00. Possible pullback at $17.00.

NEWS AND CATALYST:
The following are excerpts from yahoo finance.

October 30, 2018, NEO reported 17% growth in revenue ($69M).

Third Quarter 2018 Highlights:

•   17% increase in consolidated revenue  

•   14% increase in clinical genetic testing volume(1)

•   21% increase in Pharma Services revenue; 75% increase in Pharma Services backlog

•   Completed $135 million, net equity offering 

•   Announced acquisition of Genoptix in October for $125 million in cash and 1 million shares of NeoGenomics common stock

CHART (1 Year)

 CHART (2 Years)

FINVIZ
Finviz has a target of $20.71. Based on its EPS Q/Q of 342% it has a very strong fundamental. Sales Q/Q  is not that big which is 8.70%. But with the current news of having beaten estimates with its Q3 Earnings and Revenue, there is a big chance this stock can still soar high.

BIG CHARTS (NEO in 1 Decade vs NASDAQ). 

NEO had a huge divergence against NASDAQ. 

 BIG CHARTS (NEO in 1 Decade)

STOCKCHARTS.COM (NEO, LXFR, NTWK vs NASDAQ in 3 Years Chart)

As you can see in the comparison against NASDAQ, NEO had gained 187% compared to NASDAQ of 46.64%

STOCKCHARTS.COM (NEO vs NASDAQ in 3 months Chart)

This chart is meant to show the divergence created by NEO against the NASDAQ composite. While NASDAQ broke down on the last week of October 2018, NEO went breaking out of previous high and created new highs.

To see how to enter in this kind of stock, please go to https://excel4stocks.blogspot.com/2019/03/neo-hitting-minola-and-how-to-position.html

LXFR hitting MINOLA on stockfetcher

LXFR
Luxfer is a materials technology company, that designs, manufactures, and supplies high-performance materials, components, and high-pressure gas-containment devices for transportation, defense and emergency response, healthcare, and general industrial applications in Europe, North America, the Asia Pacific, and internationally.

It has two operations. The Gas Cylinders and Elektron.

The Gas Cylinders manufactures and markets aluminum and composite cylinders and systems, which are used in self-contained breathing apparatus, fire extinguishers, alternative fuels, bulk gas transportation, specialty gases, medical, beverages, scuba, and aerospace applications under the Luxfer Gas Cylinders brand. This operation also designs and manufactures aluminum, titanium, and magnesium plates for use in aerospace, automotive, rail, and medical products under the Superform brand.

The Elektron focuses on specialty materials based on magnesium, zirconium, and rare earths. It develops and manufactures magnesium alloys; magnesium powders; and magnesium, copper, and zinc photoengraving plates. This operation also develops and manufactures specialty zirconium products, including zirconium-based materials, zirconium oxides, fiber-optic fuel cells, and other products. The company was founded in 1898 and is based in Manchester, the United Kingdom.

NOTE:
MINOLA is the acronym of Minervini, O'Neil and Larry Williams. This a filter I created that combines the 3 strategies of these 3 wizzards of Stock Market. The filter tries to capture the Minervini SEPA strategy, the O'Neil Pocket Pivot and the ADX(14) of larry Williams. I created this filter in stockfetcher.com

TECHNICAL:
Nov. 06, 2018 flagged as MINOLA on my stockfetcher with a significant volume of 535K breaking out the Aug. 23, 2018 volume of 374K and leveled the previous volume last April 26, 2017. Based on the previous breakout last may 10, 2018 it rose from $15 to $17 and pulled back somewhere at $16.00. With this new breakout the rise is around $23.00 to $28.00. Give or take the pull back could be somewhere around $25.00 or $24.00.

NEWS: Zack bet on this stock as one one with Good Net Margin

CHART (2 Years)

CHART (1 Year)

FINVIZ:

LXFR has a very high EPS Quarter per Quarter (EPS Q/Q) which is 296% and the Sales Quarter per Quater (Sales Q/Q) is also on the positive side which is 20.30%. The target that Finviz set is $15.00 which is very low. But it could also be possible since the stock had gone very far from the 200SMA (the green line on the above chart.)

In case this stock falls to $15.00, take a look at the following chart of NMIH. A similar configuration might happen.

BIG CHART (LXFR on 1 decade against NASDAQ):
Looking at the Decade chart of LXFR on Bigcharts.com the stock had actually broken out previous high and had created a divergence against the NASDAQ chart. This divergence could mean a year of new high just like in 2013.

BIG CHART (LXFR on 1 Decade)

BIG CHART (LXFR on 1 Year)